Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
Bsteh G, Hegen H, Riedl K, Altmann P, Auer M, Berek K, Di Pauli F, Ehling R, Kornek B, Monschein T, Rinner W, Schmied C, Wurth S, Zebenholzer K, Zinganell A, Zrzavy T, Zulehner G, Deisenhammer F, Rommer P, Leutmezer F, Berger T.
Bsteh G, et al. Among authors: rommer p.
Eur J Neurol. 2021 May;28(5):1609-1616. doi: 10.1111/ene.14705. Epub 2021 Jan 18.
Eur J Neurol. 2021.
PMID: 33370478
Free PMC article.